Novel 18F labeling strategy for polyester-based NPs for in vivo PET-CT imaging.

Drug-loaded nanocarriers and nanoparticulate systems used for drug release require a careful in vivo evaluation in terms of physicochemical and pharmacokinetic properties. Nuclear imaging techniques such as positron emission tomography (PET) are ideal and noninvasive tools to investigate the biodistribution and biological fate of the nanostructures, but the incorporation of a positron emitter is required. Here we describe a novel approach for the (18)F-radiolabeling of polyester-based nanoparticles. Our approach relies on the preparation of the radiolabeled active agent 4-[(18)F]fluorobenzyl-2-bromoacetamide ([(18)F]FBBA), which is subsequently coupled to block copolymers under mild conditions. The labeled block copolymers are ultimately incorporated as constituent elements of the NPs by using a modified nano coprecipitation method. This strategy has been applied in the current work to the preparation of peptide-functionalized NPs with potential applications in drug delivery. According to the measurements of particle size and zeta potential, the radiolabeling process did not result in a statistically significant alteration of the physicochemical properties of the NPs. Moreover, radiochemical stability studies showed no detachment of the radioactivity from NPs even at 12 h after preparation. The radiolabeled NPs enabled the in vivo quantification of the biodistribution data in rats using a combination of imaging techniques, namely, PET and computerized tomography (CT). Low accumulation of the nanoparticles in the liver and their elimination mainly via urine was found. The different biodistribution pattern obtained for the "free" radiolabeled polymer suggests chemical and radiochemical integrity of the NPs under investigation. The strategy reported here may be applied to any polymeric NPs containing polymers bearing a nucleophile, and hence our novel strategy may find application for the in vivo and noninvasive investigation of a wide range of NPs.

[1]  W. Wang,et al.  Spin transport and Relaxation in Graphene , 2010, 1108.2930.

[2]  O. Thews,et al.  HPMA-LMA copolymer drug carriers in oncology: an in vivo PET study to assess the tumor line-specific polymer uptake and body distribution. , 2013, Biomacromolecules.

[3]  P. Bhattacharyya,et al.  Recent developments on graphene and graphene oxide based solid state gas sensors , 2012 .

[4]  A. Stroyuk,et al.  Photochemical synthesis and optical properties of binary and ternary metal-semiconductor composites based on zinc oxide nanoparticles , 2005 .

[5]  R. Boisgard,et al.  Fluorine‐18‐ and iodine‐125‐labelling of spiegelmers , 2003 .

[6]  M. Zielecka,et al.  Antimicrobial additives for architectural paints and impregnates , 2011 .

[7]  Oliver Thews,et al.  Radioactive labeling of defined HPMA-based polymeric structures using [18F]FETos for in vivo imaging by positron emission tomography. , 2009, Biomacromolecules.

[8]  W. Cai,et al.  18F-labeled mini-PEG spacered RGD dimer (18F-FPRGD2): synthesis and microPET imaging of αvβ3 integrin expression , 2007, European Journal of Nuclear Medicine and Molecular Imaging.

[9]  O. Thews,et al.  Modifying the body distribution of HPMA-based copolymers by molecular weight and aggregate formation. , 2011, Biomacromolecules.

[10]  M. Amiji,et al.  Poly(ethylene oxide)-modified poly(ɛ-caprolactone) nanoparticles for targeted delivery of tamoxifen in breast cancer , 2005 .

[11]  Ralph Weissleder,et al.  Nanoparticle PET-CT Imaging of Macrophages in Inflammatory Atherosclerosis , 2008, Circulation.

[12]  Y. Liu,et al.  Layer-by-layer construction of graphene/cobalt phthalocyanine composite film on activated GCE for application as a nitrite sensor , 2013 .

[13]  Michela Matteoli,et al.  Biocompatible nanocomposite for PET/MRI hybrid imaging , 2012, International journal of nanomedicine.

[14]  F. Albericio,et al.  Synthesis and in vivo evaluation of the biodistribution of a 18F-labeled conjugate gold-nanoparticle-peptide with potential biomedical application. , 2012, Bioconjugate chemistry.

[15]  Nicholas A Peppas,et al.  Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. , 2006, International journal of pharmaceutics.

[16]  Robert Langer,et al.  Polymeric nanoparticles for drug delivery. , 2010, Methods in molecular biology.

[17]  Luis M Liz-Marzán,et al.  Shape control in gold nanoparticle synthesis. , 2008, Chemical Society reviews.

[18]  Greg M Thurber,et al.  18F labeled nanoparticles for in vivo PET-CT imaging. , 2009, Bioconjugate chemistry.

[19]  F. Wuest,et al.  Synthesis and application of 4-[(18)F]fluorobenzylamine: A versatile building block for the preparation of PET radiotracers. , 2010, Organic & biomolecular chemistry.

[20]  S M Moghimi,et al.  Long-circulating and target-specific nanoparticles: theory to practice. , 2001, Pharmacological reviews.

[21]  R. Béliveau,et al.  Involvement of the low‐density lipoprotein receptor‐related protein in the transcytosis of the brain delivery vector Angiopep‐2 , 2008, Journal of neurochemistry.

[22]  Y. Picó,et al.  Determining nanomaterials in food , 2011 .

[23]  R. Weissleder,et al.  Synthesis and in vivo imaging of a 18F-labeled PARP1 inhibitor using a chemically orthogonal scavenger-assisted high-performance method. , 2011, Angewandte Chemie.

[24]  U. Narkiewicz,et al.  Study of mechanical properties of concrete with low concentration of magnetic nanoparticles , 2008 .

[25]  Development of High Drug Loaded and Customizing Novel Nanoparticles for Modulated and Controlled Release of Paclitaxel , 2014, Pharmaceutical Research.

[26]  L. Zhang,et al.  Nanoparticles in Medicine: Therapeutic Applications and Developments , 2008, Clinical pharmacology and therapeutics.

[27]  Hanno Schieferstein,et al.  Radiolabeling of Nanoparticles and Polymers for PET Imaging , 2014, Pharmaceuticals.

[28]  J. Bading,et al.  Pharmacokinetics and tumor retention of 125I-labeled RGD peptide are improved by PEGylation. , 2004, Nuclear medicine and biology.

[29]  C. Crouzel,et al.  General method to label antisense oligonucleotides with radioactive halogens for pharmacological and imaging studies. , 2000, Bioconjugate chemistry.

[30]  Deborah Pareto,et al.  Biodistribution of amino-functionalized diamond nanoparticles. In vivo studies based on 18F radionuclide emission. , 2011, ACS nano.

[31]  H. Maeda.  The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting. , 2001, Advances in enzyme regulation.

[32]  A. S. Moses,et al.  Imaging and drug delivery using theranostic nanoparticles. , 2010, Advanced drug delivery reviews.

[33]  G. Gao,et al.  Spin-dependent transport in graphene nanoribbons adsorbed with vanadium in different positions , 2013 .

[34]  Andrés Guerrero-Martínez,et al.  Nanostars shine bright for you Colloidal synthesis, properties and applications of branched metallic nanoparticles , 2011 .